NFKB1 and neoplasm: Several classes of NFκB inhibitors are currently being tested in combination with RT including IKK inhibitors [33], inhibitory peptides [34], antisense RNA [35,36], proteasome inhibitors [37,38] and dietary agents that can block at various steps leading to NFκB activation and sensitize the tumor cells to the beneficial effects of radiation.